Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-11-017219
Filing Date
2011-03-16
Accepted
2011-03-16 17:26:26
Documents
7
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 REXAHN PHARMACEUTICALS, INC 10-K 12-31-2010 form10k.htm 10-K 5043417
2 EXHIBIT 23 ex23.htm EX-23 3765
3 EXHIBIT 24 ex24.htm EX-24 14133
4 EXHIBIT 31.1 ex31_1.htm EX-31.1 13763
5 EXHIBIT 31.2 ex31_2.htm EX-31.2 13769
6 EXHIBIT 32.1 ex32_1.htm EX-32.1 8494
7 EXHIBIT 32.2 ex32_2.htm EX-32.2 8500
  Complete submission text file 0001140361-11-017219.txt   5106954
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34079 | Film No.: 11692922
SIC: 2834 Pharmaceutical Preparations